Literature DB >> 7801909

Well-differentiated hepatocellular carcinoma: clinicopathological features and results of hepatic resection.

M Sato1, Y Watanabe, T Lee, K Kito, S Kimura, Y Itoh, K Akamatsu, N Ueda.   

Abstract

OBJECTIVES: To clarify clinicopathological features and surgical results in patients with well-differentiated hepatocellular carcinoma (wd-HCC) corresponding to Edmondson's cell grading I/I-II.
METHODS: The clinicopathological characteristics, diagnosis, and results of surgery were studied in 14 wd-HCC patients who underwent limited hepatic resection.
RESULTS: All patients had liver cirrhosis and solitary tumors. The tumor sizes ranged from 10 to 25 mm. Serum alpha-fetoprotein levels were normal in 13 patients. The detection rates of sonography, computed tomography (CT), angiography, CT during arterial portography, 1-wk lipiodol CT, and 3-wk lipiodol CT were 100%, 43%, 36%, 69%, 57%, and 0%, respectively. High echoic pattern on sonography and disappearance of lipiodol 3 wk after injection were characteristic findings. There was no operative death. Although seven patients developed intrahepatic tumor recurrence, early treatment including ethanol injection therapy and arterial embolization/infusion therapy controlled the recurrences in five patients. Eleven patients are surviving 25-83 mo after surgery (mean, 44 mo); the remaining three died of pneumonia or hepatic insufficiency 44-62 mo after surgery. Eight patients received successful direct interruption surgery for concurrent esophagocardia varices. Pathological features of wd-HCCs included lack of tumor invasiveness or capsule, nuclear crowding, microacinar formation, fat deposition, presence of portal tracts, and surrounding adenomatous hyperplasia.
CONCLUSION: Wd-HCCs present atypical findings in various imagings and histology because of the earlier developmental stage of HCCs. Hepatic resection for wd-HCCs provides excellent patient survival.

Entities:  

Mesh:

Year:  1995        PMID: 7801909

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

Review 1.  [Diagnosis and differential diagnosis of hepatocellular carcinoma].

Authors:  U Drebber; H P Dienes
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

2.  Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.

Authors:  Shotaro Enomoto; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Kosaku Moribata; Tatsuya Shiraki; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  Hepatol Int       Date:  2011-01-09       Impact factor: 6.047

3.  A Life-Saving Cancer: More on the Double Whammy.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2016-04-01

Review 4.  New markers for cancer detection.

Authors:  Ivy H N Wong; Y M Dennis Lo
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

5.  Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

Authors:  S Kubo; S Nishiguchi; K Hirohashi; T Shuto; T Kuroki; S Minamitani; T Ikebe; T Yamamoto; K Wakasa; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1998-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.